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Objectives: Composite arterial grafts for coronary artery bypass grafting surgery
allow complete arterial revascularization but are limited by the inflow of a single
internal thoracic artery supplying all the grafted vessels. We reviewed the safety of
composite arterial grafts using either bilateral internal thoracic arteries or a single
internal thoracic artery and radial artery.
Methods: From January 1999 to July 2002, 402 consecutive patients receiving
composite grafts only were compared to a control group of patients (n  542)
undergoing coronary artery bypass grafting with internal thoracic artery and saphe-
nous veins operated upon by the same surgeons. Two different statistical approaches
were used to compare groups in this retrospective analysis. First, propensity score
analysis with greedy matching technique was used to match patients from each
group. Second, a multivariate analysis was performed looking at a combined patient
outcome of death, intra-aortic balloon counterpulsation utilization, myocardial in-
farction, stroke, and prolonged ventilation on all patients in both groups.
Results: After matching by propensity score, the major clinical outcomes in com-
posite arterial (n 249) and control (n 249) groups were found to be similar. The
in-hospital mortality in the composite group was 1.2% as compared with 0.4% in
matched patients (P  .62). However, patients in the composite group were found
to have a significantly longer pump time (P  .0001), longer clamp time (P 
.0001), increased incidence of prolonged mechanical ventilation (12.8% vs 4.8%; P
 .002), and higher incidence of combined morbidity outcome (13.6% vs 6.4%; P
 .007) as compared with matched patients. Multivariable analysis showed that
composite arterial grafting was an independent predictor of the combined morbidity
outcome with an odds ratio of 2.1 (1.2-3.7).
Conclusions: These findings suggest that composite arterial grafting may be asso-
ciated with an increase in risk-adjusted patient morbidity when compared with a
conventional coronary artery bypass grafting group, although a mortality difference
was not demonstrable.
Coronary artery bypass grafting (CABG) is a well-established ther-apy for patients with multivessel coronary artery disease, withexcellent short- and medium-term results.1 There are concerns,however, about long-term results of vein grafts utilized for CABG.Fitzgibbon and colleagues2 in a prospective study of 1388 patients(many of whom underwent angiography early, at 1 year, 5 years,
and up to 22.5 years after operation) have reported long-term vein graft patencies of
50%. Graft occlusion can result in return of disabling angina, the need for rehos-
pitalization, reintervention, and death.3 In contrast, it is well established that patency
rates for left internal thoracic artery (ITA) grafts to the left anterior descending
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artery are excellent compared with saphenous vein grafts
(SVGs), with patency rates at 10 years of 90%.3 Utilization
of left ITA grafts has also been demonstrated to confer a
survival benefit to patients having CABG.4
Because of the excellent results with left ITA grafts it has
been hypothesized that exclusive arterial revascularization
without SVGs would result in improved long-term results
following CABG.4-6 In support of this, there are numerous
published series of patients undergoing CABG with com-
plete arterial revascularization using a variety of arterial
conduits (eg, radial artery, left ITA, right ITA, gastroepip-
loic) demonstrating feasibility and safety.7-11 This is partic-
ularly true after recent renewed interest in and demonstra-
tion of safety with radial artery conduits.9-12
To facilitate exclusive arterial revascularization, com-
posite arterial grafting creating a Y or T graft from a
pedicled ITA (left or right) has been proposed.7-11 Although
the safety of this approach is supported by single-center
case series with excellent survival, a direct comparison with
conventional ITA and SVG cases has yet to be made. The
objective of the present study was to evaluate the safety of
composite arterial grafts by comparing outcomes to a con-
trol group of patients where left ITA and SVG were utilized,
using propensity score and multivariable analysis.
Materials and Methods
Patients
From January 1999 to July 2002, 402 consecutive patients under-
going coronary revascularization with exclusively composite arte-
rial grafts (no aortic anastomoses) utilizing either 2 ITAs or 1 ITA
in combination with a radial artery were identified. During the
same study period 542 consecutive patients undergoing CABG
that utilized the left ITA in combination with SVGs anastomosed
proximally to the aorta were identified. All surgeries were per-
formed by a group of 4 surgeons contributing to both composite
and control groups. Patients with preoperative intra-aortic balloon
counterpulsation (IABP) were excluded.
Indications for CABG surgery were based on a weekly peer-
review process, involving cardiologist, cardiac surgeons, and car-
diac radiologists. Individual patients were placed on a specific wait
list according to urgency of procedure. Cardiopulmonary bypass
(CPB) for coronary bypass surgery at our institution was per-
formed in a standardized fashion. Body temperature during the
procedure was allowed to drift to approximately 32°C. Intermittent
cold blood cardioplegic solution was delivered antegrade via the
aortic root unless otherwise indicated. The choice of conduits
and/or construction of composite grafts was based on surgeon
preferences rather than fixed criteria such as territory to graft,
degree of target vessel stenosis, vessel size, or flow. Arterial
conduits were harvested with minimal trauma (nonskeletonized
ITA) and all treated with either a papaverine solution or nitroglyc-
erine/calcium channel blocker (verapamil) solution prior to use.
The composite anastomosis, in the majority of patients, was per-
formed under cardioplegic arrest after all distal anastomoses had
been completed. Patients who had beating heart surgery (OPCAB)
were included in this analysis and this group consisted of 97
patients (10.3%).
Postoperative Management
All patients received intravenous nitroglycerin (0.1-8 ug/kg/min)
infusions for the first 24 hours unless hypotensive (systolic blood
pressure  90 mm Hg). Oral nifedipine (Adalat 10 mg by mouth
4 times a day or Adalat XL 30 mg daily; Bayer, Inc, Toronto,
Ontario, Canada) was prescribed for all patients receiving a radial
artery beginning on day 1 postoperatively for a period of 3 to 6
months. Other routine medications included daily aspirin and
resumption of cholesterol-lowering agents and -blockers.
Data Collection
Perioperative patient variables were collected by 3 full-time re-
search assistants and maintained in the Maritime Heart Center
Cardiac Surgery Database. This has been a standard practice at this
institution for all cardiac surgical cases since 1995 with regular
data validation. An elective case was defined as a patient waiting
at home prior to the procedure; in-house cases were defined as
hospitalized patients requiring surgery; urgent cases were defined
as cases where surgery were required to be performed within 24
hours to prevent further clinical deterioration; and emergency/
emergency salvage cases were those patients who required an
immediate operation. Twelve-lead electrocardiogram was recorded
before the operation, at 2 hours after surgery, and then when
clinically indicated. Electrocardiographic diagnosis criteria for
perioperative myocardial infarction (MI) were new Q-wave (0.04
ms) in at least 2 leads or electrocardiographic ST changes in
association with significant creatine kinase MB enzyme release.
Data Analysis
All analyses were performed with the Statistical Analysis Systems
software package (SAS, Release 8.2, Cary, NC). Descriptive sta-
tistics included continuous and discrete variables, which were
analyzed accordingly with an unpaired t test, Wilcoxon rank sum
test, chi-square test, and Fisher exact test.
A propensity analysis was performed modeling probability of
receiving a composite arterial graft. Briefly, a nonparsimonious
multivariable logistic regression model using clinically relevant
variables was generated to compute a propensity score for each
patient (Appendix). All clinically relevant variables were included
into the model. The propensity score (or probability of receiving a
composite graft) was then used to obtain a 1-to-1 match of com-
posite cases with CABG controls (left ITA  SVG) by a “greedy
matching” technique.13 Outcomes were compared between these
matched groups.
Finally, a multivariable logistic regression model was used to
analyze combined adverse outcomes. The fully adjusted model
included 24 patient variables, as well as the type of grafting
performed (composite versus control), individual surgeons, and
propensity score. In an additional regression analysis we included
time and experience variables as model variables. The time and
experience variables included were: composite early experience,
ITA  SVG early experience, composite late experience, ITA 
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SVG late experience, and time (early  first 18 months or late 
last 24 months).
Results
Patient Characteristics
A total of 944 consecutive patients who underwent CABG
surgery performed by 1 of the 4 surgeons experienced in
composite grafts at our center and who met our graft com-
position criteria were identified between January 1999 to
July 2002. Of these, 402 (42.6%) were composite (no sa-
phenous vein conduits, no proximal anastomoses) and the
remaining 542 were CABG controls (left ITA  SVG).
Patient characteristics of the 2 groups are listed in Table 1.
In summary, composite patients were significantly younger,
more often of male gender, with less comorbid diseases,
better New York Heart Association (NYHA) class, and less
often operated upon urgently. In addition, composite graft
patients received more distal anastomoses. The unadjusted
in-hospital mortality for the composite group was 1% and
for the control group was 2.8% (P  .06).
Comparison Using Propensity Score Analysis
The propensity score model included 24 patient variables
that are listed along with their confidence intervals in Ap-
pendix. The c-statistic for this model was 0.80 (Hosmer-
Lemeshow goodness-of-fit P  .3057). Two hundred forty-
nine of 402 composite cases (62%) could be matched to
controls. The 2 groups were well matched for all the patient
variables (Table 2). The number of grafted vessels was 3.4
 0.9 grafts in the composite group compared to 3.5  0.9
grafts in the matched group (P .28). The conduits utilized
in the composite group were the left ITA (98%), the right
ITA (19%), and radial artery (89%). The conduits utilized in
the matched group were the left ITA (100%) and SVGs. The
CPB time (128 vs 105 minutes; P  .0001) and clamp time
TABLE 1. Patient characteristics of composite arterial
grafts versus LITA  SV, in 944 unmatched cases
Preoperative patient
characteristic
Composite graft
(n  402), %
LITA  SV
(n  542), % P value
Age
60 40.6 19.6 .0001
60–74 50.0 49.3
75 9.4 31.2
Female gender 18.2 32.7 .0001
Diabetes 36.3 40.6 .18
Renal failure 1.7 6.8 .0002
Hypertension 63.7 65.5 .56
Hypercholesterolemia 86.8 79.5 .003
PVD 12.4 18.3 .015
CVD 8.2 17.9 .0001
COPD 10.7 18.3 .001
Previous CABG 5.2 2.8 .05
EF  40 9.0 16.0 .001
NYHA class
I 2.0 1.1 .003
II 14.2 9.4
III 45.3 39.5
IV 38.6 50.0
Status
Elective 61.0 45.8 .0001
Inhouse 33.1 45.4
Urgent 24 hours 5.0 7.0
Emergency 1.0 1.8
Distal anastomosis
2 8.2 16.6 .0001
3 50.5 38.9
4 32.8 31.9
5 8.5 12.6
Off-pump 9.7 10.7 .62
LITA, Left internal thoracic artery; SV, saphenous vein; PVD, peripheral
vascular disease; CVD, cerebrovascular disease; COPD, chronic lung dis-
ease; CABG, coronary artery bypass grafting; EF, ejection fraction; NYHA,
New York Heart Association.
TABLE 2. Patient characteristics of composite arterial
grafts versus LITA  SV, in 498 matched cases obtained by
greedy matching technique using propensity scores
Preoperative patient
characteristic
Composite Graft
(n  249), %
LITA  SV
(n  249), % P value
Age
60 29.7 26.1 .62
60–74 55.0 56.6
75 15.3 17.3
Female gender 21.3 23.7 .52
Diabetes 37.4 39.0 .71
Renal failure 2.8 2.8 1.00
Hypertension 66.3 62.6 .40
Hypercholesterolemia 83.9 83.5 .90
PVD 15.7 11.6 .19
CVD 12.0 12.4 .89
COPD 14.9 13.2 .61
Previous CABG 4.4 4.4 1.00
EF  40 13.2 12.0 .69
NYHA class
I 1.2 2.0 .71
II 13.6 14.9
III 43.4 45.8
IV 41.8 37.4
Status
Elective 55.0 57.4 .75
Inhouse 38.6 34.5
Urgent 24 hours 5.2 6.8
Emergency 1.2 1.2
Distal anastomosis
2 11.6 9.2 .85
3 45.4 46.6
4 32.1 32.5
5 10.8 11.6
Off-pump 8.0 8.8 .75
LITA, Left internal thoracic artery; SV, saphenous vein; PVD, peripheral
vascular disease; CVD, cerebrovascular disease; COPD, chronic lung dis-
ease; CABG, coronary artery bypass grafting; EF, ejection fraction; NYHA,
New York Heart Association.
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(102 vs 74 minutes; P .0001) were significantly longer for
the composite group compared with matched patients (Ta-
ble 3).
The mortality was 1.2% in the composite group and
0.4% in the matched group (P  .62). The length of hos-
pitalization was a median of 6 days in both groups with an
interquartile range of 5 to 8 days (P .11). Major morbidity
was not statistically different between composite and
matched groups in terms of: intra/postoperative IABP (3.6%
vs 0.8%; P  .06), postoperative MI (2.8% vs 1.6%; P 
.54), permanent stroke (2.4% vs 0.8%; P  .29), and rates
of deep sternal wound infection (1.2% vs 0.8%; P  1.00)
(Table 3). However, significantly more patients in the com-
posite group required prolonged mechanical ventilation
compared with matched patients (12.8% vs 4.8%; P 
.002). The combined outcome of death, IABP, MI, stroke,
and prolonged ventilation was also significantly higher in
the composite group compared with matched patients
(13.6% vs 6.4%; P  .007).
The 153 composite patients that failed to match from the
composite group are illustrated in Table 4. In summary,
patients who failed to match were significantly younger,
more often of male gender, with less comorbid diseases,
normal ventricular function, and performed less urgently
than the cohort that we were able to match to controls.
Comparison Using Multivariable Analysis
A multiple logistic regression analysis was performed on
the entire cohort of 944 patients. The outcome evaluated
was a combined outcome of mortality and morbidity be-
cause of the low event rate associated with individual vari-
ables. The combined outcome (n  105 events) included:
death, intra/post-IABP utilization, postoperative MI, perma-
nent stroke, and prolonged mechanical ventilation (24
TABLE 3. Perioperative outcomes for composite arterial
grafts versus LITA  SV, in 498 matched cases obtained by
greedy matching technique using propensity scores
Perioperative outcome
Composite
graft
(n  249),
n (%)
LITA  SV
(n  249),
n (%) P value
Combined outcome:
(Mort/IABP/MI/Stroke/
LongVent)
34 (13.6) 16 (6.4) .007
In-hospital mortality 3 (1.2) 1 (0.4) .62
Intra-/postop IABP 9 (3.6) 2 (0.8) .06
Periop MI 7 (2.8) 4 (1.6) .54
Stroke 6 (2.4) 2 (0.8) .29
Prolonged ventilation 
24 hours
32 (12.8) 12 (4.8) .002
Deep sternal infection 3 (1.2) 2 (0.8) 1.00
Blood products 48 (19.3) 39 (15.7) .29
Inotropes leaving OR 53 (21.3) 49 (19.7) .66
Return to OR for bleeding 4 (1.6) 5 (2.0) 1.00
Return to OR for graft
occlusion
4 (1.6) 0 (0.0) .12
Number of grafts/patients
(mean, SD)
3.4  0.9 3.5  0.9
Pump time, minutes
(median, IQR)
128 (102–160) 105 (86–133) .0001
Clamp time, minutes
(median, IQR)
102 (78–132) 74 (59–94) .0001
Postop stay, days
(median, IQR) for
patients alive at
discharge
6 (5–8) 6 (5–8) .11
LITA, Left internal thoracic artery; SV, saphenous vein; Mort, mortality; MI,
myocardial infarction; LongVent, prolonged ventilation; IABP, intra-aortic
balloon counterpulsation; OR, operating room; IQR, interquartile range.
TABLE 4. Patient characteristics of composite arterial
grafts greedy matched (n  249) versus failed to match (n
 153)
Preoperative patient
characteristic
Composite graft
greedy matched
(n  249), %
Composite graft
failed to match
(n  153), % P value
Age
60 29.7 58.2 .0001
60–74 55.0 41.8
75 15.3 0.0
Female gender 21.3 13.1 .04
Diabetes 37.4 34.6 .58
Renal failure 2.8 0.0 .05
Hypertension 66.3 59.5 .17
Hypercholesterolemia 83.9 91.5 .03
PVD 15.7 7.2 .01
CVD 12.0 2.0 .0003
COPD 14.9 3.9 .0006
Previous CABG 4.4 6.5 .35
EF  40 13.2 2.0 .0001
NYHA class
I 1.2 3.3 .22
II 13.6 15.0
III 43.4 48.4
IV 41.8 33.3
Status
Elective 55.0 70.6 .01
Inhouse 38.6 24.2
Urgent 24
hours
5.2 4.6
Emergency 1.2 0.6
Distal anastomosis
2 11.6 2.6 .0003
3 45.4 58.8
4 32.1 34.0
5 10.8 4.6
Off-pump 8.0 12.4 .15
PVD, Peripheral vascular disease; CVD, cerebrovascular disease; COPD,
chronic lung disease; CABG, coronary artery bypass grafting; EF, ejection
fraction; NYHA, New York Heart Association.
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hours). A c-statistic was calculated as a measure of the
sensitivity and specificity of the logistic regression model
and was 0.81. In the fully adjusted model, 7 independent
predictors of the combined morbidity outcome were iden-
tified (Table 5). Composite arterial grafting was found to be
an independent predictor of the combined mortality/morbid-
ity outcome with an odds ratio of 2.1 (1.2-3.7). The other
independent predictors for the combined outcome were:
ejection fraction less than 40%, chronic lung disease
(COPD), urgent surgery, cerebrovascular disease (CVD),
peripheral vascular disease (PVD) and NYHA class IV.
Because composite grafting is technically demanding
and may be subject to a surgical learning curve, we created
a second logistic regression model that included time and
experience variables defined as: composite early experi-
ence, ITA  SVG early experience, composite late experi-
ence, ITA  SVG late experience, and time (early or late).
Using this approach early composite grafting experience
remained an independent predictor of the combined mor-
bidity outcome (death, IABP, MI, stroke, and prolonged
ventilation) with an odds ratio of 4.1 (2.0-8.4). The c-
statistic for this model was 0.82.
Reinterventions
Four patients in the composite group had postoperative
angiograms because of evidence of recurrent myocardial
ischemia (day 0 to day 10). In 3 of these patients there was
stenosis at the composite anastomosis, while in the fourth
patient (redo CABG in the setting of a patent left ITA)
angiography demonstrated an unrecognized injury to the old
left ITA graft. All 4 patients were regrafted and eventually
discharged home in good condition. No patients in the
matched group were reoperated upon for graft failure.
Discussion
Arterial grafting has increasingly been advocated for the
treatment of coronary artery disease in an attempt to im-
prove the long-term results.7-11 In support of the safety of
arterial grafting, multiple retrospective case series have
been published with excellent outcomes.7-11 Lytle and col-
leagues,5 in a large retrospective review of 10,124 patients
comparing risk-adjusted outcomes of patients who received
2 ITA grafts with patients receiving only 1 ITA graft,
reported single ITA grafting was an independent predictor
of death and reintervention. Recently a case-matched study
comparing saphenous vein graft (n  956) to radial artery
graft (n  478) showed an improved freedom from reinter-
vention up to 36 months in radial artery conduit patients.12
Composite arterial grafting, in which a free arterial graft is
anastomosed to the side of a pedicled ITA graft (usually
left), is also gaining in popularity. This approach facilitates
complete arterial grafting and limits manipulation of the
aorta normally associated with performing proximal anas-
tomoses.7-9 Recent case series attest to the safety of this
approach, but to date a comparative study has not been
carried out.7-11 In fact, variations in patient selections for
total arterial grafting, choice of arterial conduit, and the use
of composite arterial grafts have made comparison to estab-
lished techniques of ITA grafts and SVGs problematic.
We report our experience with total arterial grafting
employing composite arterial grafting using either 2 ITAs or
1 ITA and radial artery compared with control patients
having CABG surgery performed with left ITA and SVGs.
The overall mortality in the composite group of 1% com-
pared favorably to other series.7-11 We have attempted to
make meaningful comparisons between the composite
group and a contemporaneous set of left ITA vein graft
control cases operated upon by the same surgeons. To do
this we have employed 2 statistical approaches based on
propensity modeling, a technique that has been strongly
advocated in several recent publications, in an effort to
better evaluate treatment comparisons from nonrandomized
clinical experiences.14,15 The propensity score is the prob-
ability of a patient receiving a given intervention (in this
case composite arterial grafting) based on a nonparsimoni-
ous model derived from preoperative patient variables. The
propensity model thus reduces many variables to a single
balancing score, facilitating meaningful intergroup compar-
isons. We utilized 2 approaches, namely the creation of
matched pairs based on propensity score and logistic regres-
sion analysis of outcomes in which propensity score partic-
ipated as a variable.
Case matching based on propensity score is superior to
conventional case matching, which typically utilizes a
smaller set of variables for matching.13-16 Using this tech-
nique the composite arterial and control groups were re-
markably well matched in terms of known risk predictors of
outcomes following CABG surgery. The overall mortality
and major morbidity between groups were not statistically
TABLE 5. Multivariable preoperative predictors of com-
bined outcome (Mortality/IABP/MI/Stroke/Prolonged Ven-
tilation); combined outcome occurred in 105 of 944 cases
Variable Odds ratio Range
EF  40 3.6 2.0–6.6
COPD 2.6 1.5–4.7
Urgent 2.5 1.2–4.9
CVD 2.3 1.3–4.4
Composite graft 2.1 1.2–3.7
PVD 2.0 1.2–3.5
NYHA class IV 1.8 1.1–3.0
EF, Ejection fraction; COPD, chronic lung disease; CVD, cerebrovascular
disease; PVD, peripheral vascular disease; NYHA, New York Heart Asso-
ciation.
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different. However, requirement for prolonged mechanical
ventilation for more than 24 hours was significantly higher
in the composite group compared with matched patients.
Prolonged mechanical ventilation, defined as greater than
24 hours in this study, has previously been demonstrated to
be a reliable surrogate marker for increased overall morbid-
ity and mortality following CABG surgery.17-19 However, a
potential explanation for this observation may be the sig-
nificantly longer CPB and clamp times used in patients
undergoing composite grafts.
In addition, a combined mortality and morbidity outcome
was generated in an attempt to address the low event rate
and the small sample size of our analysis while maintaining
clinical relevance. The choice of the variables in this com-
bined outcome was based on their clinical association with
poor patient outcome following CABG surgery.17 Compos-
ite arterial grafting was shown to be significantly associated
with the combined outcome compared with matched pa-
tients. It is important to note that we were unable to match
153 composite arterial cases (38%). When we examined the
patient characteristics of the unmatched composite cases in
comparison with the 249 composite arterial cases we were
able to match, the unmatched cases were significantly lower
risk than their matched counterparts (younger, more often
male, fewer incidences of ejection fraction  40%, less
PVD, CVD, COPD, and less often urgent). Thus our case-
matched result is likely to be more representative of the
higher-risk subset of our composite arterial group, but al-
ternatively the adverse effects of composite grafting may
also be overestimated by the matching strategy.
To allow meaningful comparisons with the entire cohort
of 944 patients, we utilized a multiple logistic regression
analysis using the previously defined combined morbidity/
mortality outcome. Using this analysis, composite arterial
grafting was found to be an independent predictor of our
combined morbidity/mortality outcome (mortality/IABP/
MI/stroke/prolonged vent) with an odds ratio of 2.1 (95%
confidence interval 1.2-3.7). Because of the technically de-
manding nature of composite arterial grafting, we employed
a second logistic regression model to look for a learning
curve effect. Additional time and experience variables were
added to the model and included early composite graft (first
18 months) and late composite graft (final 24 months)
experiences. In this final analysis, early composite graft
experience was found to be an independent predictor of
adverse outcomes as compared with other grafting strate-
gies. This finding suggests that there is a significant learning
curve effect related to technical competence impacting out-
comes of composite arterial grafting. Alternatively patient
selection may have improved with increasing experience
with the technique.
Taken together, these data indicate that composite grafts
were independently associated with increased patient mor-
bidity (prolonged ventilation) and a combined end point of
mortality and major morbidity. Our observations may be the
result of inadequate flow reserve in a single ITA or due to
technical error resulting in compromised flow in 1 or both
limbs of the composite graft. Indeed, 4 patients in the
composite arterial group returned to the operating room for
graft revision while none of the control group underwent
graft revision. One must bear in mind that a number of case
series provide evidence that the angiographic patency and
flow capacity of composite grafts are good, with good short-
and medium-term results.8-10,20,21 The outcome difference
between composite arterial cases and controls may be re-
lated to longer pump and clamp times in the composite
group, reflecting increased technical difficulty of exclusive
arterial anastomoses. It may be advisable to alter our strat-
egy and perform the composite anastomosis at the begin-
ning of the operation prior to initiating CPB. This strategy
could significantly shorten aortic clamp times and pump
times and allow evaluation of flow in both limbs of the
composite graft prior to distal anastomosis.
In summary, our findings raise some concerns about the
routine use of composite arterial grafting. However, one
must be cautious in interpreting our findings as our analysis
was limited by its retrospective design and relatively small
sample size. Another limitation of our analysis was the use
of a combined outcome where 1 variable (prolonged venti-
lation) was already shown to be significantly different be-
tween groups, potentially disproportionally influencing the
combined outcome. Nevertheless, there are several factors
involved in the choice of conduits for CABG patients made
by surgeons, some of which may not be included among the
patient variables available for adjustment. The lack of mor-
tality difference between the groups provides some reassur-
ance that the differences in the incidence of prolonged
ventilation and combined outcome were perhaps in part
discretionary on the part of caregiver’s awareness of the
composite arterial technique employed and the prolonged
perfusion times. Our observations support the need for a
prospective, multi-institutional study to better determine
both the short- and long-term outcomes of exclusive arterial
grafting as alluded to by a recent small randomized trial
indicating that short-term result following composite graft-
ing resulted in improved freedom from adverse cardiac
events when compared with conventional ITA and SVG
grafting.22
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APPENDIX
Logistic regression model to generate propensity scores for com-
posite graft (n  402) vs lima  sv graft (542): the logistic
procedure, odds ratio estimates
Effect Point estimate
95% Wald
confidence
limits P value
OPCAB 0.594 0.343 1.030 .06
4 distals 2.119 1.082 4.150 .03
4 distals 3.792 2.209 6.512 .001
3 distals 4.580 2.737 7.666 .001
Emergency 1.476 0.337 6.470 .61
Urgent 0.608 0.302 1.226 .16
In-house 0.636 0.450 0.900 .01
NYHA class
IV 0.631 0.187 2.127 .46
III 0.737 0.222 2.450 .62
II 0.682 0.194 2.388 .55
Surgeon 3 0.155 0.092 0.260 .001
Surgeon 2 0.320 0.210 0.488 .001
Surgeon 1 0.928 0.561 1.536 .77
Age 74 0.135 0.081 0.225 .001
Age 60–74 0.461 0.325 0.656 .001
Sex 0.591 0.409 0.855 .005
Diabetes 0.785 0.571 1.078 .13
CRF 0.408 0.161 1.036 .06
HTN 1.162 0.842 1.604 .36
Hypercholesterolemia 1.459 0.957 2.222 .08
PVD 0.911 0.579 1.433 .69
CVD 0.454 0.279 0.740 .002
COPD 0.548 0.350 0.858 .01
PREVCAB 1.836 0.812 4.154 .14
EF 40 0.573 0.352 0.934 .03
Association of Predicted Probabilities and Observed Responses
Pairs 217884 c-statistic 0.796
LITA, Left internal thoracic artery; SV, saphenous vein; OPCAB, beating
heart surgery; NYHA, New York Heart Association; CRF, renal insufficiency;
HTN, hypertension; PVD, peripheral vascular disease; CVD, cerebrovascu-
lar disease; COPD, chronic lung disease; Prevcab, previous surgery; EF,
ejection fraction.
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